TGF-b/Smad3 inhibition synergizes with PPARg agonism to reduce fibrosis and enhance functional beige adipogenesis
RNA-seq (gene expression) · mouse · 18 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 18 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE268791_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1118757 and SRA study SRP511091. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 18 samples.
How we read this: 6 replicated groups read from 18 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8299562 CD_mock_1 CD_mock
- GSM8299563 CD_mock_2 CD_mock
- GSM8299564 CD_mock_3 CD_mock
- GSM8299565 CD_TGF-b_1 CD_TGF-b
- GSM8299566 CD_TGF-b_2 CD_TGF-b
- GSM8299567 CD_TGF-b_3 CD_TGF-b
- GSM8299568 CD_TGF-b/SB431542_1 CD_TGF-b/SB431542
- GSM8299569 CD_TGF-b/SB431542_2 CD_TGF-b/SB431542
- GSM8299570 CD_TGF-b/SB431542_3 CD_TGF-b/SB431542
- GSM8299571 HFD_mock_1 HFD_mock
- GSM8299572 HFD_mock_2 HFD_mock
- GSM8299573 HFD_mock_3 HFD_mock
- GSM8299574 Itga5-High_DM_1 Itga5-High_DM
- GSM8299575 Itga5-High_DM_2 Itga5-High_DM
- GSM8299576 Itga5-High_DM_3 Itga5-High_DM
- GSM8299577 Itga5-Low_DM1 Itga5-Low_DM
- GSM8299578 Itga5-Low_DM2 Itga5-Low_DM
- GSM8299579 Itga5-Low_DM3 Itga5-Low_DM
- GSE207029 Blockade of avb8 integrin synergizes with checkpoint inhibition to enhance anti-tumor immunity through Cxcl9-dependent augmentation of CD8+ T cell cytotoxicity 12 samples shares inhibition, synergizes, enhance
- GSE241176 Fibroblast-specific TGF-b signaling mediates dysfunction, fibrosis and hypertrophy in a mouse model of obesity-associated type 2 diabetes [RNA-seq: Smad3 in dbdb] 12 samples shares smad3, fibrosis
- GSE235623 MERTK inhibition for the treatment of tissue fibrosis [RNA-seq] 86 samples shares inhibition, fibrosis
- GSE325466 Transcriptomics of S3 segment in mice: response to type 1 diabetes, SGLT1/2 inhibition, or GLP1 receptor agonism response to type 1 diabetes, SGLT1/2 inhibition or GLP1 receptor agonism 54 samples shares inhibition, agonism
- GSE306012 Temporal inhibition of ADAM17 in fibroblasts reduces stiffness and promotes vascularization following myocardial infarction 28 samples shares inhibition, reduce
- GSE311912 Probiotics Complex Synergizes with FOLFOX to Enhance Antitumor Response and Ameliorate Chemotherapy-induced Intestinal Toxicity via Upregulation of NAD+ Metabolism 27 samples shares synergizes, enhance
- GSE272274 Effects of hepatic mARC1 inhibition in a mouse model of liver fibrosis 25 samples shares inhibition, fibrosis
- GSE281510 Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophy 24 samples shares inhibition, reduce
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.